CN Stock MarketDetailed Quotes

002020 Zhejiang Jingxin Pharmaceutical

Watchlist
  • 11.02
  • -0.02-0.18%
Market Closed Sep 10 15:00 CST
9.49BMarket Cap13.46P/E (TTM)

Zhejiang Jingxin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Jingxin Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 15, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.09B
--
+11.59%
Net Income
--
232.66M
--
+39.57%
Analyst Rating
Strong Buy

Sep 10, 2024

Zhejiang Jingxin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.013B--
--2024/FY-- / 4.431B--
Mar 30, 20242023/FY3.999B / 4.017B--
--2020/FY3.260B / 3.786B--
--2019/FY3.647B / 3.782B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 5.013B--
--2024/FY-- / 4.431B--
Mar 30, 20242023/FY3.999B / 4.017B--
--2020/FY3.260B / 3.786B--
--2019/FY3.647B / 3.782B--

Unlock Free Earnings Estimates

Zhejiang Jingxin Pharmaceutical Earnings Reports

  • Zhejiang Jingxin Pharmaceutical: Half-year report for the year 2024.

    Aug 14 12:00 ET

  • Zhejiang Jingxin Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 14 12:00 ET

  • Jingxin Pharmaceutical: Report for the first quarter of 2024

    Apr 23 12:00 ET

  • Jingxin Pharmaceutical: 2023 Annual Report Summary

    Mar 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Strong Buy

    • Strong Buy

      85.71%

    • Buy

      14.29%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg